The University of Chicago Header Logo

Connection

Anita Chong to Transplantation, Heterologous

This is a "connection" page, showing publications Anita Chong has written about Transplantation, Heterologous.
Connection Strength

3.074
  1. Expression of complement regulatory proteins in accommodated xenografts induced by anti-alpha-Gal IgG1 in a rat-to-mouse model. Am J Transplant. 2008 Jan; 8(1):32-40.
    View in: PubMed
    Score: 0.246
  2. Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts. J Immunol. 2004 Jun 15; 172(12):7235-8.
    View in: PubMed
    Score: 0.194
  3. Integrative multi-omics profiling in human decedents receiving pig heart xenografts. Nat Med. 2024 May; 30(5):1448-1460.
    View in: PubMed
    Score: 0.193
  4. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection. J Immunol. 2003 Feb 01; 170(3):1531-9.
    View in: PubMed
    Score: 0.177
  5. Role of CD4+ and CD8+ T cells in the rejection of concordant pancreas xenografts. Transplantation. 2002 Nov 15; 74(9):1236-41.
    View in: PubMed
    Score: 0.174
  6. Acute xenograft rejection mediated by antibodies produced independently of TH1/TH2 cytokine profiles. Am J Transplant. 2002 Jul; 2(6):526-34.
    View in: PubMed
    Score: 0.170
  7. CTLA-41g in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal ab production in GT-Ko mice. Am J Transplant. 2002 Jan; 2(1):41-7.
    View in: PubMed
    Score: 0.164
  8. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice. Xenotransplantation. 2000 Nov; 7(4):275-83.
    View in: PubMed
    Score: 0.151
  9. Anti-galactose-alpha(1,3)Galactose antibody production in alpha1, 3-galactosyltransferase gene knockout mice after xeno- and allotransplantation. Transplant Proc. 2000 Aug; 32(5):844-5.
    View in: PubMed
    Score: 0.149
  10. Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation. Transplant Proc. 2000 Aug; 32(5):1003-4.
    View in: PubMed
    Score: 0.149
  11. Nondepleting anti-CD4 but not anti-CD8 antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1, 3-galactosyl-transferase knock-out mice. Transplant Proc. 2000 Aug; 32(5):1005.
    View in: PubMed
    Score: 0.149
  12. Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific. Xenotransplantation. 2000 Feb; 7(1):48-57.
    View in: PubMed
    Score: 0.144
  13. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model. J Immunol. 1998 Aug 15; 161(4):2044-51.
    View in: PubMed
    Score: 0.130
  14. Quantitation of the changes in splenic architecture during the rejection of cardiac allografts or xenografts. Transplantation. 1997 Aug 15; 64(3):448-53.
    View in: PubMed
    Score: 0.121
  15. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine. Transplant Proc. 1996 Apr; 28(2):684.
    View in: PubMed
    Score: 0.110
  16. Evidence that tilapia islets do not express alpha-(1,3)gal: implications for islet xenotransplantation. Xenotransplantation. 2004 May; 11(3):276-83.
    View in: PubMed
    Score: 0.048
  17. Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance. J Immunol. 2002 May 15; 168(10):5352-8.
    View in: PubMed
    Score: 0.042
  18. The structure of anti-Gal immunoglobulin genes in naïve and stimulated Gal knockout mice. Transplantation. 2001 Dec 15; 72(11):1817-25.
    View in: PubMed
    Score: 0.041
  19. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. Transplantation. 2001 May 27; 71(10):1385-9.
    View in: PubMed
    Score: 0.039
  20. Differential immune response to carbohydrate epitopes on allo- and xenografts: implications for accommodation. Transplant Proc. 2000 Aug; 32(5):991-3.
    View in: PubMed
    Score: 0.037
  21. Anti-galactose-alpha(1,3) galactose antibody production in alpha1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. Transpl Immunol. 2000 Jun; 8(2):129-37.
    View in: PubMed
    Score: 0.037
  22. In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression. Transplantation. 1999 Jul 15; 68(1):100-9.
    View in: PubMed
    Score: 0.035
  23. FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. Transplantation. 1998 Oct 15; 66(7):832-7.
    View in: PubMed
    Score: 0.033
  24. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation. Transplantation. 1998 Sep 27; 66(6):692-8.
    View in: PubMed
    Score: 0.033
  25. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice. Transplantation. 1998 May 27; 65(10):1310-4.
    View in: PubMed
    Score: 0.032
  26. Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats. Transplantation. 1997 Jul 27; 64(2):317-21.
    View in: PubMed
    Score: 0.030
  27. Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice. Transplant Proc. 1997 Jun; 29(4):2155.
    View in: PubMed
    Score: 0.030
  28. Successful xenotransplantation of adult porcine islets in NOD and BALB/c mice with leflunomide and cyclosporine. Transplant Proc. 1997 Jun; 29(4):2166-7.
    View in: PubMed
    Score: 0.030
  29. Gene gun-mediated gene transfer and expression in rat islets. Transplant Proc. 1997 Jun; 29(4):2209-10.
    View in: PubMed
    Score: 0.030
  30. Delayed xenograft rejection in the concordant hamster heart into Lewis rat model. Transplantation. 1996 Jul 15; 62(1):90-6.
    View in: PubMed
    Score: 0.028
  31. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation. Transplant Proc. 1996 Apr; 28(2):691-2.
    View in: PubMed
    Score: 0.028
  32. Leflunomide controls rejection in hamster to rat cardiac xenografts. Transplantation. 1994 Oct 15; 58(7):828-34.
    View in: PubMed
    Score: 0.025
  33. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts. Transplant Proc. 1994 Jun; 26(3):1263-5.
    View in: PubMed
    Score: 0.024
  34. Direct killing of xenograft cells by CD8+ T cells of discordant xenograft recipients. Transplantation. 2002 Dec 15; 74(11):1587-95.
    View in: PubMed
    Score: 0.011
  35. Development and characterization of anti-Gal B cell receptor transgenic Gal-/- mice. Transplantation. 2002 May 27; 73(10):1549-57.
    View in: PubMed
    Score: 0.011
  36. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest. 2000 Feb; 105(3):301-10.
    View in: PubMed
    Score: 0.009
  37. Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes. Transplant Proc. 1998 Mar; 30(2):463-4.
    View in: PubMed
    Score: 0.008
  38. Leflunomide-based immunosuppression for porcine islet xenotransplantation. Transplant Proc. 1998 Mar; 30(2):515.
    View in: PubMed
    Score: 0.008
  39. Effect of gene gun-mediated CTLA4IG and Fas ligand gene transfection on concordant xenogeneic islet graft rejection. Transplant Proc. 1998 Mar; 30(2):589.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.